Delcath Systems Stock Short Ratio
| DCTH Stock | USD 11.27 0.68 6.42% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Delcath Systems' long-term financial health and intrinsic value.
Delcath | Short Ratio | Build AI portfolio with Delcath Stock |
Delcath Systems Company Short Ratio Analysis
Delcath Systems' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Delcath Systems Short Ratio | 2.30 X |
Most of Delcath Systems' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Delcath Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Delcath Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Delcath Systems is extremely important. It helps to project a fair market value of Delcath Stock properly, considering its historical fundamentals such as Short Ratio. Since Delcath Systems' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Delcath Systems' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Delcath Systems' interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Delcath Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Delcath Systems has a Short Ratio of 2.3 times. This is 41.03% lower than that of the Health Care Equipment & Supplies sector and 38.99% lower than that of the Health Care industry. The short ratio for all United States stocks is 42.5% higher than that of the company.
Delcath Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Delcath Systems' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Delcath Systems could also be used in its relative valuation, which is a method of valuing Delcath Systems by comparing valuation metrics of similar companies.Delcath Systems is currently under evaluation in short ratio category among its peers.
Delcath Systems ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Delcath Systems' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Delcath Systems' managers, analysts, and investors.Environmental | Governance | Social |
Delcath Systems Institutional Holders
Institutional Holdings refers to the ownership stake in Delcath Systems that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Delcath Systems' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Delcath Systems' value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 343.1 K | Geode Capital Management, Llc | 2025-03-31 | 308.3 K | Kennedy Capital Management Inc | 2025-03-31 | 292.1 K | Cubist Systematic Strategies, Llc | 2025-03-31 | 282.5 K | Palisades Investment Partners, Llc | 2025-06-30 | 270.3 K | Soleus Capital Management, L.p. | 2025-03-31 | 232.7 K | Qube Research & Technologies | 2025-03-31 | 217 K | The Informed Momentum Company (formerly Eam Investors) | 2025-03-31 | 208.6 K | Blackrock Inc | 2025-03-31 | 193.4 K | Rosalind Advisors, Inc. | 2025-03-31 | 2.9 M | Vanguard Group Inc | 2025-03-31 | 1.4 M |
Delcath Fundamentals
| Return On Equity | -0.28 | ||||
| Return On Asset | -0.0151 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 310.41 M | ||||
| Shares Outstanding | 34.83 M | ||||
| Shares Owned By Insiders | 2.73 % | ||||
| Shares Owned By Institutions | 45.23 % | ||||
| Number Of Shares Shorted | 2.18 M | ||||
| Price To Earning | (0.12) X | ||||
| Price To Book | 4.59 X | ||||
| Price To Sales | 6.86 X | ||||
| Revenue | 37.2 M | ||||
| Gross Profit | 45.72 M | ||||
| EBITDA | (12.18 M) | ||||
| Net Income | (26.39 M) | ||||
| Cash And Equivalents | 10.2 M | ||||
| Cash Per Share | 1.19 X | ||||
| Total Debt | 1.04 M | ||||
| Debt To Equity | 3.13 % | ||||
| Current Ratio | 1.57 X | ||||
| Book Value Per Share | 2.40 X | ||||
| Cash Flow From Operations | (18.68 M) | ||||
| Short Ratio | 2.30 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Price To Earnings To Growth | (0.05) X | ||||
| Target Price | 24.08 | ||||
| Number Of Employees | 96 | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 369.33 M | ||||
| Total Asset | 76.59 M | ||||
| Retained Earnings | (531.55 M) | ||||
| Working Capital | 67.62 M | ||||
| Current Asset | 14.6 M | ||||
| Current Liabilities | 6.31 M | ||||
| Net Asset | 76.59 M |
About Delcath Systems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Delcath Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Delcath Systems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Delcath Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out Delcath Systems Piotroski F Score and Delcath Systems Altman Z Score analysis. For more detail on how to invest in Delcath Stock please use our How to Invest in Delcath Systems guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Delcath Systems. If investors know Delcath will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Delcath Systems listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Revenue Per Share | Quarterly Revenue Growth 5.303 | Return On Assets | Return On Equity |
The market value of Delcath Systems is measured differently than its book value, which is the value of Delcath that is recorded on the company's balance sheet. Investors also form their own opinion of Delcath Systems' value that differs from its market value or its book value, called intrinsic value, which is Delcath Systems' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Delcath Systems' market value can be influenced by many factors that don't directly affect Delcath Systems' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Delcath Systems' value and its price as these two are different measures arrived at by different means. Investors typically determine if Delcath Systems is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Delcath Systems' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.